SCHEMBL14033367

SCHEMBL14033367

CN(C)CCOc1ccc(C(Cl)c2ccccc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.63
LSS P48449 1/20 0.53
LMNA P02545 3/20 0.51
CYP2D6 P10635 3/20 0.51
HTR6 P50406 3/20 0.51
CYP1A2 P05177 2/20 0.51
CHRM2 P08172 2/20 0.51
CHRM4 P08173 2/20 0.51
CHRM5 P08912 2/20 0.51
ADRA2A P08913 2/20 0.51
CHRM1 P11229 2/20 0.51
ADRA2B P18089 2/20 0.51
CHRM3 P20309 2/20 0.51
SLC6A2 P23975 2/20 0.51
HRH2 P25021 2/20 0.51
HTR2A P28223 2/20 0.51
HTR2C P28335 2/20 0.51
SLC6A4 P31645 2/20 0.51
OPRM1 P35372 2/20 0.51
DRD3 P35462 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20460249 0.85 LTA4H (0.65) LTA4HLSSLMNACYP2D6HTR6
SCHEMBL16204295 0.85 LTA4H (0.65) LTA4HLSSLMNACYP2D6HTR6
SCHEMBL8476224 0.84 LTA4H (0.63) LTA4HLSSLMNACYP2D6HTR6
SCHEMBL29129692 0.83 HRH3 (0.58) LTA4HLSSCYP1A2HRH3KDM4E
SCHEMBL13305547 0.83 LTA4H (0.62) LTA4HLSSLMNACYP2D6HTR6
SCHEMBL20460282 0.83 LTA4H (0.66) LTA4HLSSLMNACYP2D6HTR6
SCHEMBL1405661 0.80 LTA4H (0.85) LTA4HLSSLMNACYP2D6HTR6
SCHEMBL13305558 0.80 CHRM2 (0.64) LTA4HLSSLMNACYP2D6HTR6
SCHEMBL17164698 0.80 LTA4H (0.58) LTA4HLSSLMNACYP2D6HTR6
SCHEMBL13305563 0.80 LTA4H (0.59) LTA4HLSSLMNACYP2D6HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed